Welcome to our dedicated page for Alphatec Holdings SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alphatec Holdings, Inc. filings document the reporting record of a spine-focused medical technology company. Its Form 8-K disclosures include quarterly and annual operating results, surgical and EOS revenue commentary, non-GAAP profitability measures, preliminary financial information and related press-release exhibits.
The company’s regulatory filings also cover material financing agreements, including senior secured credit facilities, revolving borrowing capacity, term-loan arrangements and references to convertible senior notes. Proxy and governance filings document director elections, board composition, executive and director compensation, equity awards, committee matters and other shareholder voting disclosures.
Alphatec Holdings (ATEC) – Form 4: EVP, People & Culture Craig E. Hunsaker disclosed two open-market sales executed under a pre-arranged Rule 10b5-1 plan adopted 5-Mar-2025.
- 08-Aug-2025: Sold 50,000 common shares at a weighted avg. price of $15.00.
- 09-Aug-2025: Sold 10,876 common shares at $15.33.
After the transactions, Hunsaker directly owns 1,389,142 ATEC shares, down from roughly 1.45 million. The sales represent about 4.2 % of his direct stake.
No derivative security activity was reported. The filing contains no new operational or financial guidance; it solely documents the insider’s change in beneficial ownership.
Form 144 filing for Alphatec Holdings, Inc. (ATEC)
The filing discloses a proposed sale of 18,092 common shares with an aggregate market value of $269,688.68, scheduled for 08/05/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired on 08/05/2025 as restricted stock vesting under a registered plan and payment is listed as compensation. The filing also reports prior sales by the same person in the past three months: 12,878 shares on 08/01/2025 (gross proceeds $154,016.00) and 1,500 shares on 07/10/2025 (gross proceeds $17,936.00).
Administrative note: Filer identification fields (CIK/CCC/name) are not populated in the provided text.
What this filing shows
The filing notifies a proposed sale of 16,666 Alphatec Holdings (ATEC) common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $247,823.42. The sale is slated for 08/05/2025 on NASDAQ.
Why it matters
The shares being sold were granted as performance stock units (8,624) and restricted stock units (8,042). The filer, Scott Lish, has completed multiple recent sales under trading plans, totaling 136,022 shares sold in the past three months for gross proceeds of $1,721,457.50. This is a disclosure of insider liquidity events and shows pre-planned sales activity rather than new purchases.